JP2015049050A5 - - Google Patents

Download PDF

Info

Publication number
JP2015049050A5
JP2015049050A5 JP2013178620A JP2013178620A JP2015049050A5 JP 2015049050 A5 JP2015049050 A5 JP 2015049050A5 JP 2013178620 A JP2013178620 A JP 2013178620A JP 2013178620 A JP2013178620 A JP 2013178620A JP 2015049050 A5 JP2015049050 A5 JP 2015049050A5
Authority
JP
Japan
Prior art keywords
amount
test substance
urine
compounds represented
dysuria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013178620A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015049050A (ja
JP6222629B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013178620A priority Critical patent/JP6222629B2/ja
Priority claimed from JP2013178620A external-priority patent/JP6222629B2/ja
Publication of JP2015049050A publication Critical patent/JP2015049050A/ja
Publication of JP2015049050A5 publication Critical patent/JP2015049050A5/ja
Application granted granted Critical
Publication of JP6222629B2 publication Critical patent/JP6222629B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013178620A 2013-08-29 2013-08-29 排尿障害のバイオマーカー Active JP6222629B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013178620A JP6222629B2 (ja) 2013-08-29 2013-08-29 排尿障害のバイオマーカー

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013178620A JP6222629B2 (ja) 2013-08-29 2013-08-29 排尿障害のバイオマーカー

Publications (3)

Publication Number Publication Date
JP2015049050A JP2015049050A (ja) 2015-03-16
JP2015049050A5 true JP2015049050A5 (enExample) 2016-07-28
JP6222629B2 JP6222629B2 (ja) 2017-11-01

Family

ID=52699210

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013178620A Active JP6222629B2 (ja) 2013-08-29 2013-08-29 排尿障害のバイオマーカー

Country Status (1)

Country Link
JP (1) JP6222629B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7031104B2 (ja) * 2017-09-29 2022-03-08 国立大学法人山梨大学 難治性夜間頻尿・夜間多尿症バイオマーカー、これを用いた検査方法及び難治性夜間頻尿・夜間多尿症の予防剤又は改善剤のスクリーニング方法
JP7294709B2 (ja) * 2017-09-29 2023-06-20 国立大学法人山梨大学 難治性夜間頻尿・夜間多尿症バイオマーカーの測定方法及び難治性夜間頻尿・夜間多尿症の予防剤又は改善剤のスクリーニング方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59162899A (ja) * 1983-03-08 1984-09-13 Kyoto Daiichi Kagaku:Kk β‐ヒドロキシ酪酸の定量用組成物
US7700792B2 (en) * 2003-12-26 2010-04-20 Ono Pharmaceutical Co., Ltd. Highly active lysophosphatidic acid and method of screening therewith
CA2695674A1 (en) * 2007-08-16 2009-02-26 Metabolon, Inc. Metabolomic profiling of prostate cancer
CA2764049A1 (en) * 2009-06-04 2010-12-09 Charite Universitaetsmedizin Berlin Means and methods for diagnosing prostate carcinomas
JP2013515270A (ja) * 2009-12-22 2013-05-02 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 前立腺癌の代謝学的プロファイリング
EP2776832A4 (en) * 2011-11-11 2015-06-03 Metabolon Inc BIOMARKER FOR BUBBLE CANCER AND METHOD FOR ITS USE

Similar Documents

Publication Publication Date Title
Schmid et al. Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies
JP2012211908A5 (enExample)
WO2016044338A3 (en) Methods and systems for diagnosing sleep disorders
JP2016500110A5 (enExample)
CA2863393A1 (en) A multi-biomarker-based outcome risk stratification model for pediatric septic shock
EP3751283A3 (en) Blood-based screen for detecting neurological diseases in primary care settings
JP2016531903A5 (enExample)
JP2018509934A5 (enExample)
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
WO2012047899A3 (en) Novel dna hypermethylation diagnostic biomarkers for colorectal cancer
EP2579043A4 (en) DETECTION METHOD
WO2009001545A1 (ja) 移植片対宿主疾患の検査および治療方法
JP2015511721A5 (enExample)
JP2016512201A5 (enExample)
CY1123265T1 (el) Μια αναλυση κυτταρικως μεσολαβουμενης ανοσοαποκρισhς
EP2942010A4 (en) TINNITE DIAGNOSIS AND TESTING DEVICE
EA201490946A1 (ru) Способ количественной оценки лечения рака
GB201014837D0 (en) Biomarker signatures and uses thereof
RU2016149127A (ru) Калибровка уровня аналита с использованием базисного уровня аналита
WO2012037199A3 (en) Methods for diagnosis and prognosis of inflammatory bowel disease using cytokine profiles
BR112012024175A2 (pt) hbf e a1m como marcadores de estágio precoce para preeclampsia
WO2016164467A8 (en) Imaging device and method for detection of disease
EP2385365A3 (en) Method for tumor detection using T1 measurements and a SQUID-based tabletop NMR system
TR201906195T4 (tr) Niemann pıck hastalığının teşhisi için metot.
WO2012109258A3 (en) Compositions adn methods for monitoring oxalate